Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 47-52 , 2 January 2004

Markers of endothelial dysfunction in hyperglycaemic Asian Indian subjects

Received 5 December 2002 ,Revised 20 March 2003 ,Accepted 25 March 2003.

References 

  1. Bannan S, Mansfield MW, Grant PJ. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia. 1998;41:460–466
  2. Bertello P, Velligo F, Pinna G, Gurioli L, Molino P, Alban S, et al. Plasma endothelin in NIDDM patients with and without complications. Diabetes Care. 1994;17:574–577
  3. Bluher M, Unger R, Rassoul F, Richter V, Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes. Diabetologia. 2002;45:210–216
  4. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48:1856–1862
  5. Carlos T, Kovach N, Schwartz B, Rosa M, Newman B, Waynes E, et al. Human monocytes bend to 2 cytokine-induced adhesive ligands on cultured human EC: endothelial leukocyte adhesion molecule-1 and VCAM-1. Blood. 1991;77:2266–2271
  6. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. New England Journal of Medicine. 1996;334:150–154
  7. Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving H-H, Feldt-Rasmussen B. Plasma concentrations of ICAM-1 and VCAM-1 are elevated in patients with type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabetic Medicine. 2000;17:644–649
  8. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. Journal of Cardiovascular Pharmacology. 1998;32(Suppl. 3):S54–S61
  9. Definition, diagnosis and classification of diabetes mellitus and its complication. Report of consultation. Report 250. Geneva: WHO, 1999.
  10. Ferri C, Desideri G, Baldoncini R, Bellini B, De Angelis C, Mazzocchi C, et al. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes. 1998;47:660–667
  11. Foster-Swanson A, Swartzentruber M, Roberts P, Feld R, Johnson M, Wong S, et al. Reference interval studies of the rate-blanked creatinine/Jaffe method on BM/Hitachi systems in six U.S. laboratories. Clin Chem. 1994;Vol 40:1057: Abstract No. 361
  12. Haffner SM. The importance of hyperglycaemia in the non-fasting state to the development of cardiovascular disease. Endocrine Reviews. 1998;19:583–592
  13. Hlubocka Z, Umnerova VV, Heller S, Peleska J, Jindra A, Jachymova M, et al. Circulating ICAM-1, endothelin-1 and vWF markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACEI. Journal of Human Hypertension. 2002;16(8):557–562
  14. Inone A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto MK, et al. The human endothelin family: the structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proceedings of the National Academy of Sciences of the United States of America. 1989;86:2863–2867
  15. John GW, Gray MR, Bates DL, Beacham JL. Enzyme immunoassay — a new technique for estimating HbA1c. Clinical Chemistry. 1993;39:663–666
  16. Kannel WB, Larson M. Long-term epidemiologic prediction of coronary disease. The Framingham experience. Cardiology. 1993;82:137–152
  17. LeFebvre PJ, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabetic Medicine. 1998;15(Suppl. 4):S63–S68
  18. Matsumoto K, Sera Y, Nakamura H, Ucki Y, Miyake S. Serum concentrations of soluble adhesion molecules are related to degree of hyperglycaemia and insulin resistance in patients with type 2 diabetes mellitus. DRCP. 2002;55:131–138
  19. Matsumoto K, Sera Y, Abe Y, Ueki Y, Miyake S. Serum concentration of soluble VCAM-1 and e-selectin are elevated in insulin resistant patients with type 2 diabetes. Diabetes Care. 2001;24(9):1697–1698
  20. Mattei P, Virdis A, Ghiadoni L, Taddei S, Salvetti A. Endothelial function in hypertension. Journal of Nephrology. 1997;10:192–197
  21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RL. Homoestasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  22. Mizia-Steck K, Zahorstra-Markiewicz B, Mandecki T, Janowska J, Szulc A, Jastrzebska-Maj E. Serum levels of selected adhesion molecules in patients with coronary artery disease. International Journal of Cardiology. 2002;83(2):143–150
  23. Morise T, Takeuchi Y, Kawano M, Koni I, Takeda R. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care. 1995;18:87–89
  24. Pepinsky B, Hession C, Chen L-L, Moy P, Bierkly L, Jakubowsky A, et al. Structure/function studies of VCAM-1. Journal of Biological Chemistry. 1992;267:17820–17826
  25. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in urban population in India. Diabetologia. 1997;40:232–237
  26. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801–809
  27. Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin levels in patients with essential hypertension. Letter New England Journal of Medicine. 1990;322:205
  28. Snehalatha C, Ramachandran A, Satyavani K, Vijay V, Haffner SM. Specific insulin and proinsulin concentration in non-diabetic South Indians. Metabolism. 1998;47:230–233
  29. Snehalatha C, Ramachandran A, Vijay V, Viswanathan M. Differences in plasma insulin responses in urban and rural Indians: a study in Southern-Indians. Diabetic Medicine. 1994;11:445–448
  30. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolaemia and is related to the lipoprotein (a) level. Journal of Clinical Investigation. 1994;93:50–55
  31. Stad RK, Buurman WA. Current views on structure and function of endothelial adhesion molecules. Cell Adhesion and Communication. 1994;2:261–268
  32. Stauton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 1988;52:925–933
  33. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 1992;33:306–310
  34. Varley H, Gowenlock AH, Bell M. In: Practical clinical biochemistry, 5th ed. vol. 1:Great Britain: Willian Heinmann Medical Books; 1980;p. 388–400
  35. Wang L, Yu Z, Mao T. Relationship between elevated plasma endothelin-1 level and renal function in patients with diabetic nephropathy. Zhonghua Neike Zazhi. 1995;5:318–321
  36. Yanagisawa M, Kurihara H, Kimura S, Tomotx Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor by vascular EC. Nature. 1988;332:411–451
  37. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet. 1988;ii:530–533

PII: S1056-8727(03)00037-0

doi: 10.1016/S1056-8727(03)00037-0

Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 47-52 , 2 January 2004

Article Tools

* Image Usage & Resolution